https://oxfordhealthcrf.nihr.ac.uk/trials/dfp/2026-11-03T16:03:16+00:00https://oxfordhealthcrf.nihr.ac.uk/trials/isap-impact-of-semaglutide-in-amyloid-positivity-the-isap-proof-of-concept-study/2026-11-03T16:03:16+00:00https://oxfordhealthcrf.nihr.ac.uk/trials/abate-part-1/2026-11-03T16:03:16+00:00https://oxfordhealthcrf.nihr.ac.uk/trials/abate-part-2/2026-11-03T16:03:16+00:00https://oxfordhealthcrf.nihr.ac.uk/trials/aromapt-sc-1001/2026-11-03T16:03:16+00:00https://oxfordhealthcrf.nihr.ac.uk/trials/bhc-brain-health-clinic/2026-11-03T16:03:16+00:00https://oxfordhealthcrf.nihr.ac.uk/trials/retain/2026-11-03T16:03:16+00:00https://oxfordhealthcrf.nihr.ac.uk/trials/wn45447-study-trontier-2/2026-11-03T16:03:16+00:00https://oxfordhealthcrf.nihr.ac.uk/trials/study-of-mk-2214-in-participants-with-early-alzheimers-disease/2026-11-03T16:03:16+00:00https://oxfordhealthcrf.nihr.ac.uk/trials/cvhb937a12201-study-novartis/2026-11-03T16:03:16+00:00https://oxfordhealthcrf.nihr.ac.uk/trials/d-cyphr-2/2026-11-03T18:14:07+00:00https://oxfordhealthcrf.nihr.ac.uk/trials/glad/2026-11-03T18:16:09+00:00https://oxfordhealthcrf.nihr.ac.uk/trials/smile-bioresource/2026-11-03T18:18:17+00:00